AD-VEC

Adenovirus Vector Technology: Next Generation Systems for Medical Therapy

 Coordinatore UNIVERSITY OF GLASGOW 

 Organization address address: University Avenue
city: GLASGOW
postcode: G12 8QQ

contact info
Titolo: Mr.
Nome: Joe
Cognome: Galloway
Email: send email
Telefono: +44 141 330 3884

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 1˙947˙545 €
 EC contributo 1˙947˙545 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2012-IAPP
 Funding Scheme MC-IAPP
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-03-01   -   2017-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITY OF GLASGOW

 Organization address address: University Avenue
city: GLASGOW
postcode: G12 8QQ

contact info
Titolo: Mr.
Nome: Joe
Cognome: Galloway
Email: send email
Telefono: +44 141 330 3884

UK (GLASGOW) coordinator 689˙692.94
2    UMEA UNIVERSITET

 Organization address address: UNIVERSITETOMRADET
city: UMEA
postcode: 901 87

contact info
Titolo: Dr.
Nome: Niklas
Cognome: Arnberg
Email: send email
Telefono: +46 90 7858440

SE (UMEA) participant 546˙509.06
3    MAGYAR TUDOMANYOS AKADEMIA AGRARTUDOMANYI KUTATOKOZPONT

 Organization address address: BRUNSZVIK STREET 2
city: MARTONVASAR
postcode: 2462

contact info
Titolo: Dr.
Nome: Agnes
Cognome: Gaal
Email: send email
Telefono: +36 22 569 570

HU (MARTONVASAR) participant 253˙970.64
4    BATAVIA BIOSERVICES BV

 Organization address address: ZERNIKEDREEF 9
city: LEIDEN
postcode: 2333 CK

contact info
Titolo: Dr.
Nome: Menzo
Cognome: Havenga
Email: send email
Telefono: +31 8886 69842

NL (LEIDEN) participant 230˙979.11
5    CRUCELL HOLLAND BV

 Organization address address: ARCHIMEDESWEG 4
city: LEIDEN
postcode: 2333 CN

contact info
Titolo: Dr.
Nome: Jerome
Cognome: Custers
Email: send email
Telefono: +31 71 5199146

NL (LEIDEN) participant 226˙394.03

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

disease    clinical    cardiovascular    pre    medical    adenoviruses    human    synergistic    adenovirus    vec    infectious    unmet    academic    genomes    vectors    ad    industrial   

 Obiettivo del progetto (Objective)

'We propose a programme (AD-VEC) involving two industrial and three academic partners with the aim to identify new adenoviral vectors as vehicles in novel medical applications for cardiovascular disease and infectious disease. This will be achieved through broad knowledge exchange between partners with complimentary and cutting edge technological and in-depth skills relating to adenovirus phylogeny, biology and pathology in order to explore and exploit adenovirus existing in nature as new vectors in areas of unmet clinical need such as cardiovascular disease and infectious disease. Our major objectives of AD-VEC are:

(1) The provision of adenovirus genomes from novel rare human and non-human adenoviruses and engineering of these genomes to develop high quality recombinant adenovirus vectors expressing reporter genes;

(2). To provide detailed evaluation of novel adenovirus vectors with respect to infectivity, receptor usage, tropism, and the interaction with the blood and immune system;

(3). To evaluate these novel vectors at the pre-clinical level in areas of unmet clinical need, both using in vitro and in vivo studies.

These three key objectives will enable excellence in adenovirus research amongst the AD-VEC consortium members through creating a synergistic and unique opportunity in this research field. The synergies are those that cross academic and industrial boundaries and create access to a pipeline of activity that will include basic virology, new assay development, novel preclinical models, pre-clinical manufacture and vector testing. This provides empowerment to the research teams through synergistic industry/academia collaborations developed towards a common goal, i.e. exploiting adenoviruses for medical therapy.'

Altri progetti dello stesso programma (FP7-PEOPLE)

ISLAMICFASHION (2013)

Islamic fashion and the politics of belonging in contemporary Turkey

Read More  

WOX IN BREAST CANCER (2008)

"Contribution of the WW domain-containing oxidoreductase, WWOX, gene toward mammary tumorigenesis"

Read More  

CP ASSEMBLY IN CILIA (2011)

"Role of the tubulin posttranslational modifications and microtubule severing protein, katanin in the cilia central pair assembly."

Read More